Latigo Biotherapeutics, Inc.
LTGO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002056611
In the last 90 days, Latigo Biotherapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Superinvestors holding LTGO, Q2 2026
No superinvestor reported holding LTGO in Q2 2026.